Saturday, February 24, 2024
wellness India Expo
Home Tags Insulin

Tag: Insulin

Biocon Biologics successfully completes integration of Viatris’ biosimilar business in 31...

In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept

USV partners Biogenomics to launch INSUQUICK, the first biosimilar Insulin Aspart...

INSUQUICK is 100% Made in India with the potential to improve treatment access for people with diabetes

Insulin pumps market to hit US$ 13.34 billion by 2032: Report

The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities and rising production of advanced insulin pumps

Insulin pumps market to hit US$ 13.34 billion by 2032

The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities

Insulin pumps market to hit US$ 13.34 billion by 2032, predicts report

Demand for patch insulin pumps is predicted to rise at a CAGR of 10% from 2022 to 2032

Diabetes Technology: Improving Care Through Innovation

Research indicates that continuous glucose monitoring has helped people with Type 2 diabetes either on long-acting insulin therapy or non-insulin OAD therapy, significantly reducing their HbA1c levels

Roche launches ACCU-FINE® pen needles for painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)

Biocon Biologics partners IDF to increase access to diabetes care

Becomes the first biosimilar insulin company to partner with International Diabetes Federation for enabling affordable access to insulins to people with diabetes worldwide.................

World Diabetes Day: Understanding importance of safe insulin injection technique

Based on this year’s theme, ‘The Nurse and Diabetes’, it becomes even more important to raise awareness around the crucial role that nurses play in treating people living with diabetes.......................

Opioid addiction treating drug may be repurposed for type 2 diabetes

Researchers from the Indian Institute of Technology, Mandi (IIT Mandi) have unraveled the mechanism by which insulin overload in the body causes insulin resistance that is associated with diabetes......................